New triple therapy for the diagnosis of CKD-MBD: a cross-sectional study in Shanxi province
The triple combination of β2-microglobulin+parathyroid hormone+blood urea nitrogen indicators can play the crucial role of a sensitive indicator for the early diagnosis of chronic kidney disease-mineral and bone metabolic disorder and in preventing or delaying the progress of chronic kidney disease-mineral and bone metabolic disorder.
Authors
- Liping Feng (ORCID: https://orcid.org/0000-0002-2936-7397)
- Daihe Yang
- Rongshan Li (ORCID: https://orcid.org/0000-0002-8082-4389)
- Yun Zhou (ORCID: https://orcid.org/0000-0002-7075-6351)
- Bo Huang (ORCID: https://orcid.org/0000-0002-3028-1945)
- Zhi Wang (ORCID: https://orcid.org/0000-0001-8315-3501)
- Yuanyuan Gao (ORCID: https://orcid.org/0000-0002-0839-0248)
- Zhi Yu Zhao
- Wendong Sui
- ZiTong Zhang
Institutions
- Fujian University of Traditional Chinese Medicine (CN)
- Shanxi Medical University (CN)
- Shanxi University (CN)
- Shanxi Province Hospital of Traditional Chinese Medicine (CN)
- Second Hospital of Shanxi Medical University (CN)
- Shanxi University of Traditional Chinese Medicine (CN)
- Qinghai Provincial Peoples Hospital (CN)
- Shaoxing People's Hospital (CN)
- Shanxi Cardiovascular Hospital (CN)
- UCSI University (MY)
Publication Details
- Journal
- BMJ Open
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1136/bmjopen-2023-081485
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Shanxi Province
- Shanghai University of Traditional Chinese Medicine